Lynn Yoffee (email@example.com)
Lynn Yoffee is the News Director for both BioWorld and Medical Device Daily. She leads a team of journalists from around the world that produces daily insider intelligence on key business, scientific and regulatory news related to the drug development and medical device sectors. Lynn managed the BioWorld group in the mid 1990s and rejoined the team in 2010. With 20+ years of diversified experience in health care and medical science publishing for targeted B2B and consumer audiences, Lynn has managed, conceived and launched more than two dozen specialty publications on health and medical topics ranging from nanotechnology to plastic surgery.
Jennifer Boggs (firstname.lastname@example.org)
Jennifer Boggs joined the BioWorld group in 2004 as a staff writer after working for a number of years in newspapers. She was promoted to the position of assistant managing editor in 2008 and in 2011 was appointed as BioWorld's managing editor. Jennifer was part of a BioWorld team that in 2009 produced a series examining how the recession impacted key biotechnology arenas which garnered a Specialized Information Publishers Association award. More recently, she won another SIPA award for her work covering Sanofi-Aventis SA's efforts to acquire Genzyme Corp., one of the biggest acquisition deals in the history of the biotech industry.
Peter Winter (email@example.com)
Peter Winter is a seasoned science journalist based in Ottawa, Canada and has been writing about and analyzing the progress of the biotech industry since the early 1980s. He is editor of BioWorld Insight, a weekly news service that tracks the financial and business trends of the biopharmaceutical industry. He was the founder and editor of Canadian Biotech News, a weekly newsletter that served the industry for 20 years. He received his undergraduate degree from the University of London and is the recipient of the Science Journalism Laureate Award from Purdue University (2009).
Anette Breindl, PhD (firstname.lastname@example.org)
Anette Breindl, PhD has been BioWorld's science editor since 2004. Prior to joining BioWorld, she planned and executed corporate communications strategies for biotechnology companies at Akins + Associates, a public relations firm focused exclusively on life sciences clients. She has also worked as a freelance writer for U.S. and German publications, and co-authored several peer-reviewed papers. Anette earned a PhD from the Leibniz Institute for Neurobiology in Magdeburg, Germany, and a BA from the University of California at Berkeley. She has been a recipient of research scholarships from the National Science Foundation and its German equivalent, the Deutsche Forschungsgemeinschaft. Anette is a member of the National Association of Science Writers.
Mari Serebrov (email@example.com)
As the regulatory editor for BioWorld, Mari Serebrov provides news and perspective on regulated and developing markets from around the world. Upon joining BioWorld in 2011, she immediately became focused on the emerging biosimilars sector and quickly became an expert through her in-depth coverage of the space. In 2013, she authored BioWorld’s first biosimilars report, The Biosimilars Game: A Scorecard for Opportunities, Threats and Critical Strategies. She followed that in 2014 with Biosimilars: A Global Perspective of a New Market – Opportunities, Threats and Critical Strategies 2014. Mari is a senior-level writer and editor with 25+ years of diversified experience in publishing for academic, business-to-business and consumer audiences. With a bachelor’s degree in public relations and master’s degrees in journalism and history, Mari also taught advertising and PR at public and private universities and ran her own PR firm.
Randy Osborne (firstname.lastname@example.org)
Randy Osborne has been a writer and editor in biotech for 15 years, mostly at BioWorld, with several years at The Pink Sheet and Deloitte. He also has contributed to Nature Biotechnology and www.xconomy.com. His journalism career, spanning more than 35 years, includes general interest, feature, investigative and technical writing for daily, weekly and monthly newspapers and magazines, as well as radio news. His work has appeared in Newsweek, the Chicago Tribune, Atlanta Journal-Constitution, St. Louis Post-Dispatch, San Francisco Bay Guardian, The Progressive magazine, among others. During off hours, he is director of the nonprofit Carapace, a free monthly event of true personal stories told by ordinary people in Atlanta, which began in 2010 as an offshoot of The Moth in New York, and became independent a year later.
Marie Powers (email@example.com)
Marie Powers was a contributing writer for BioWorld Today before joining the staff in 2011, serving as staff writer until she was named news editor in 2015. With more than 25 years on the health care beat, she served as editor of specialty publications in neurology, orthopedic surgery and managed care and contributed to many other industry publications, including ENT Today and Managed Care Contracting & Reimbursement Advisor. She also served for nearly a decade as contributing editor to Technology Transfer Tactics and has been published in consumer magazines ranging from Glamour to Field and Stream. A longtime member of the Association of Health Care Journalists (AHCJ), in 2014 Marie was awarded an AHCJ-National Library of Medicine Fellowship.
Michael Fitzhugh (firstname.lastname@example.org)
Michael Fitzhugh joined the BioWorld team as a staff writer in 2014. He has contributed to and edited several in-depth annual reports about health care's ever changing landscape as an editor in Burrill & Co.'s San Francisco-based media group while reporting about biopharma's unfolding story. Prior to that, he covered biotechnology and high tech companies for American City Business Journals. He received his MJ from the University of California at Berkeley's Graduate School of Journalism and holds a BA from the University of Michigan. When unplugged from reporting, he enjoys spending time with his young children and playing fiddle in Berkeley, Calif.
Nuala Moran (email@example.com)
Nuala Moran has been part of the BioWorld team since 1996, covering the scientific and commercial development of the sector in Europe. She is a former managing editor of Nature and was Innovation Editor of the UK national newspaper, The Independent on Sunday. In 2006 Nuala was named as a Science Journalism Laureate by Purdue University.
Cormac Sheridan (firstname.lastname@example.org)
Based in Dublin, Ireland, Cormac Sheridan has been writing about all aspects of the European and global biotechnology industry for the past 15 years, during which time he has been a correspondent for BioWorld and a regular contributor to many other international and national publications. He has also been a guest lecturer on the BSc in genetics program at University College Cork (UCC) for the last eight years. He has a BSc in microbiology from UCC and an MA in journalism from Dublin City University.
|Ann Duncan (Ann.Duncan@thomsonreuters.com)|
Ann C. Duncan has been senior production editor for BioWorld since 2005. Prior to joining BioWorld, she spent nine years at AHC Media in Atlanta as production editor on several monthly healthcare publications. Ann worked for many years as an administrative assistant and office manager for various companies, including the YMCA, but made a midlife career change and returned to college to earn her BS in communication. She and her daughter both graduated from Kennesaw State University at about the same time. Ann has continued her studies with graduate courses in communication at Georgia State University.
Amanda Lanier (email@example.com)
Amanda Lanier joined the BioWorld team in 2004. She currently serves as the production editor for BioWorld Insight, BioWorld Asia, and various market reports, manages the BioWorld Highlights and MDD Highlights e-zines, and does editing and graphic design for BioWorld's market reports. Her work has earned numerous awards from the Specialized Information Publishers Foundation. Prior to joining BioWorld, Amanda worked as a features writer. She has a BA in communications from Oglethorpe University.
|Karen Pihl-Carey (Karen.Pihl-Carey@thomsonreuters.com)|
Karen Pihl-Carey is database editor for the financial analysis publication BioWorld Insight and the web-based publication BioWorld Snapshots. She also writes for BioWorld Today and was part of the team that won a first place award for best reference publication or directory from the Specialized Information Publishers Foundation for BioWorld's 2010 State of the Industry Report. Prior to joining BioWorld in 1999 as a staff writer, she was a daily newspaper journalist.
Donald R. Johnston (firstname.lastname@example.org)
Donald R. Johnston is senior director, current awareness for the Thomson Reuters IP & Science division. Don has worked with BioWorld Today, Medical Device Daily and their related biopharma and med-tech news and data products since 1994. Don graduated from the University of California, Berkeley and also has a master's degree in journalism from Columbia University in New York. He was a newspaper reporter and editor in both consumer and trade magazine publishing before entering the newsletter business. He is a frequent speaker at both industry and publishing events, and is proud to have been at every Biotechnology Industry Organization (BIO) meeting since Toronto in 1994.
Our address has changed:
BioWorld | 115 Perimeter Center Place
Suite: 1100 | Atlanta, Georgia 30346, USA
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2016 Thomson Reuters. Reproduction, reposting content is strictly prohibited.
Sign up for Highlights FREE e-mail newsletter